CD47 and neoplasm: For example, ROS-responsive hydrogels loaded with gemcitabine and anti-PD-1 antibodies enable prolonged antibody release and effective tumor treatment, while fibrin gel loaded with anti-CD47 antibodies encapsulated in calcium carbonate nanoparticles facilitates macrophage-mediated tumor cell removal.